These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23301959)

  • 1. Role of platelets in neurodegenerative diseases: a universal pathophysiology.
    Behari M; Shrivastava M
    Int J Neurosci; 2013 May; 123(5):287-99. PubMed ID: 23301959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An insight into ultrastructural and morphological alterations of platelets in neurodegenerative diseases.
    Shrivastava M; Vivekanandhan S
    Ultrastruct Pathol; 2011 May; 35(3):110-6. PubMed ID: 21405949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
    Thompson A; Boekhoorn K; Van Dam AM; Lucassen PJ
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():28-42. PubMed ID: 18184368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs).
    Limviphuvadh V; Tanaka S; Goto S; Ueda K; Kanehisa M
    Bioinformatics; 2007 Aug; 23(16):2129-38. PubMed ID: 17553855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
    Sheta EA; Appel SH; Goldknopf IL
    Expert Rev Proteomics; 2006 Feb; 3(1):45-62. PubMed ID: 16445350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Compounds Preventing Neurodegenerative Diseases Through Autophagic Activation.
    Huang Z; Adachi H
    J UOEH; 2016 Jun; 38(2):139-48. PubMed ID: 27302727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
    Dib M; Garrel C; Favier A; Robin V; Desnuelle C
    J Neurol; 2002 Apr; 249(4):367-74. PubMed ID: 11967639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases.
    Migliore L; Fontana I; Colognato R; Coppede F; Siciliano G; Murri L
    Neurobiol Aging; 2005 May; 26(5):587-95. PubMed ID: 15708433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application.
    Kermer P; Liman J; Weishaupt JH; Bähr M
    Neurodegener Dis; 2004; 1(1):9-19. PubMed ID: 16908969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome and neurodegeneratıve diseases.
    Catalgol B; Grune T
    Prog Mol Biol Transl Sci; 2012; 109():397-414. PubMed ID: 22727428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species: stuck in the middle of neurodegeneration.
    Patten DA; Germain M; Kelly MA; Slack RS
    J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mouse models of neurodegenerative diseases.
    Trancikova A; Ramonet D; Moore DJ
    Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular bases of neurodegenerative processes].
    Nieoullon A
    Therapie; 1998; 53(1):21-9. PubMed ID: 9773096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological aspects of human neurodegenerative diseases.
    Hörtnagl H; Hellweg R
    Wien Klin Wochenschr; 1997 Sep; 109(16):623-35. PubMed ID: 9311102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical potential of minocycline for neurodegenerative disorders.
    Blum D; Chtarto A; Tenenbaum L; Brotchi J; Levivier M
    Neurobiol Dis; 2004 Dec; 17(3):359-66. PubMed ID: 15571972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets and psychiatry: lessons learned from old and new studies.
    Camacho A; Dimsdale JE
    Psychosom Med; 2000; 62(3):326-36. PubMed ID: 10845346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.